Topical dosage form of valdecoxib: Preparation and pharmacological evaluation

Author:

Kesavanarayanan K.,Nappinnai Mohanavelu,Ilavarasan Raju

Abstract

Topical dosage form of valdecoxib: Preparation and pharmacological evaluationValdecoxib, a selective COX-2 inhibitor, produces serious side effects when given orally. This has led to its withdrawal. Topical application of valdecoxib was formulated and evaluated for its efficacy and safety. Standard procedures were followed and male Wistar albino rats were used to test the anti-inflammatory effect and effect in hyperalgesic conditions. Ointments, creams, and gels containing valdecoxib 1% (m/m) were prepared. These were tested for physical appearance, pH, spreadability, drug content uniformity,in vitrodiffusion. Gel prepared using Carbopol 940 (F-X) was selected after the analysis of the results. Formulation F-X was evaluated for acute skin irritancy, anti-inflammatory effect, optimum effective concentration of valdecoxib, effect on hyperalgesia, inhibition of the granulation tissue formation and anti-arthritic effect. Determination of valdecoxib in test animals plasma and determining the blood clotting time and bleeding time were conducted to study the safety of topical valdecoxib. Valdecoxib gel containing 1% (m/m) of the drug was significantly (p< 0.05) more effective in inhibiting hyperalgesia associated with inflammation, compared to placebo gel, but exhibited significantly (p< 0.05) lower suppression of inflammation than commercial rofecoxib gel. Concentration of valdecoxib used in the preparation minimizes the risk of systemic effects, as shown by the analysis of rat plasma for the presence of valdecoxib; hence, this may be the alternative to oral preparations. The bleeding and clotting time showed no significant difference before and after application of F-X.

Publisher

Walter de Gruyter GmbH

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Reference19 articles.

1. Formulation and evaluation of topical bases of ketoprofen;V. Dhavse;Eastern Pharm,1997

2. http://www.fda.gov/cder/drug

3. Remington's Pharmaceutical Sciences (Ed. A. Oslo), 16th ed., Lea Febiger, Philadelphia 1980, p. 1525.

4. Topical and peripherally acting analgesics;J. Sawynok;Pharmacol. Rev,2003

5. The Theory and Practice of Industrial Pharmacy (Eds. L. Lachman and H. A. Lieberman), 3rd ed., Varghese Pub. House, Bombay 1987, pp. 534-563.

Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. ACECLOFENAC LOADED FILM FORMING GELS: IN VIVO STUDY;Indian Drugs;2023-07-03

2. DEVELOPMENT AND EVALUATION OF HERBAL FORMULATION FOR THE TREATMENT OF ACNE;International journal of pharmaceutical sciences and research;2014-06-01

3. Formulation and clinical evaluation of some new nalidixic acid topical formulations;Journal of Drug Delivery Science and Technology;2014

4. Novel formulation and clinical evaluation of nalidixic acid ointment in impetigo;Journal of Drug Delivery Science and Technology;2012

5. Meloxicam Carbopol-Based Gels: Characterization and Evaluation;Current Drug Delivery;2011-07-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3